Myriad Genetics Inc
F:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
B
|
Bank of Nova Scotia
XMUN:BKN
|
CA |
|
I
|
Iovance Biotherapeutics Inc
F:2LB
|
US |
Wall St Price Targets
MYD Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for
MYD is 10.76 EUR with a low forecast of 6.85 EUR and a high forecast of 17.8 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
10.76
EUR
According to Wall Street analysts, the average 1-year price target for
MYD is 10.76 EUR with a low forecast of 6.85 EUR and a high forecast of 17.8 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.